Latest News about Moderna Inc
Recent news which mentions Moderna Inc
From CNBC.com News
From CNBC.com News
Trump says he will give RFK Jr. a major health role if he wins the White House. Here's what that means for patients, drugmakers
November 05, 2024
From CNBC.com News
Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 17, 2024
From Benzinga
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
October 16, 2024
From CNBC.com News
Cramer's Lightning Round: 'Buy more' Pfizer
September 17, 2024
From CNBC.com News
5 things to know before the stock market opens Thursday
September 12, 2024
From CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
September 12, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
August 27, 2024
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Friday
August 23, 2024
From CNBC.com News
CNBC Daily Open: Stocks slide ahead of Powell speech
August 22, 2024
From CNBC.com News
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days
August 22, 2024
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
August 20, 2024
From CNBC.com News
From CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
From CNBC.com News
From CNBC.com News
3 actions extraordinary people take to achieve what seems impossible, from the co-founder of Moderna
June 11, 2024
From CNBC.com News
5 things to know before the stock market opens
June 11, 2024
From CNBC.com News
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
June 10, 2024
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
From CNBC.com News
Cramer's Lighting Round: Sell AMC
May 24, 2024
From CNBC.com News